{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:46:13Z","timestamp":1783352773602,"version":"3.54.6"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T00:00:00Z","timestamp":1320710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00296-011-2211-5","type":"journal-article","created":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T13:19:00Z","timestamp":1320671940000},"page":"511-516","source":"Crossref","is-referenced-by-count":24,"title":["Correlation of serum prolactin levels and disease activity in systematic lupus erythematosus"],"prefix":"10.1007","volume":"33","author":[{"given":"Mansoor","family":"Karimifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Sayed","family":"Bonakdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Purajam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,8]]},"reference":[{"key":"2211_CR1","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/rheumatology\/36.9.986","volume":"36","author":"CC Mok","year":"1997","unstructured":"Mok CC, Lau CS, Tan SC (1997) Prolactin profile in a cohort of Chinese SLE patients. Br J Rheumatol 36:986\u2013989","journal-title":"Br J Rheumatol"},{"key":"2211_CR2","first-page":"37","volume":"59","author":"CM Huang","year":"1997","unstructured":"Huang CM, Chou CT (1997) Hyperprolactinemia in SLE. Chin Med J 59:37\u201341","journal-title":"Chin Med J"},{"key":"2211_CR3","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.4049\/jimmunol.147.11.3780","volume":"147","author":"R McMurray","year":"1991","unstructured":"McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE (1991) Prolactin influences autoimmune disease activity in the female B\/W mouse. J Immunol 147:3780\u20133787","journal-title":"J Immunol"},{"key":"2211_CR4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0889-857X(05)70166-6","volume":"26","author":"SE Walker","year":"2000","unstructured":"Walker SE, Jacobson JD (2000) Roles of prolactin and gonadotrophinreleasing hormone in rheumatic diseases. Rheum Dis Clin North Am 26:713\u2013736","journal-title":"Rheum Dis Clin North Am"},{"key":"2211_CR5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00000441-199204000-00003","volume":"303","author":"LJ Jara","year":"1992","unstructured":"Jara LJ, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR (1992) Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci 303:222\u2013226","journal-title":"Am J Med Sci"},{"key":"2211_CR6","first-page":"476","volume":"23","author":"M Neidhart","year":"1996","unstructured":"Neidhart M (1996) Elevated serum prolactin or elevated prolactin\/cortisol ratio are ssociated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 23:476\u2013481","journal-title":"J Rheumatol"},{"key":"2211_CR7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/096120339600500107","volume":"5","author":"SH Allen","year":"1996","unstructured":"Allen SH, Sharp GC, Wang G et al (1996) Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus 5:30\u201337","journal-title":"Lupus"},{"key":"2211_CR8","first-page":"268","volume":"14","author":"C Lavalle","year":"1987","unstructured":"Lavalle C, Loyo E, Paniagna R (1987) Correlation study between prolactin and androgen in male patients with SLE. J Rheumatol 14:268\u2013272","journal-title":"J Rheumatol"},{"key":"2211_CR9","first-page":"1569","volume":"17","author":"M Folomeev","year":"1990","unstructured":"Folomeev M, Prokaeva T, Nassonova V et al (1990) Prolactin level in man with SLE and RA (Letter). J Rheumatol 17:1569\u20131570","journal-title":"J Rheumatol"},{"key":"2211_CR10","first-page":"349","volume":"18","author":"L Jara-Quezada","year":"1999","unstructured":"Jara-Quezada L, Graef A, Lavalle C (1999) Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol 18:349\u2013353","journal-title":"J Rheumatol"},{"issue":"6","key":"2211_CR11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1191\/096120398678920361","volume":"7","author":"P Jimena","year":"1998","unstructured":"Jimena P, Aguirre MA, Lopez-Curbelo A, de Andres M, Garcia-Courtay C, Curado MJ (1998) Prolactin levels in patient with systemic lupus erythematosus: a case controlled study. Lupus 7(6):383\u2013386","journal-title":"Lupus"},{"issue":"2","key":"2211_CR12","first-page":"629","volume":"23","author":"D Buskila","year":"1996","unstructured":"Buskila D, Lober M, Neumann L, Flusser D, Shoenfeld Y (1996) No correlation between prolactin level and clinical activity in patients with systemic lupis erythematosus. J Rheumatol 23(2):629\u2013632","journal-title":"J Rheumatol"},{"issue":"5","key":"2211_CR13","first-page":"2357","volume":"25","author":"CC Mok","year":"1998","unstructured":"Mok CC, Lau CS, Lee KW, Wong RW (1998) Hyperprolactinemia in males with systemic lupus erythematosus. J Rheumatol 25(5):2357\u20132363","journal-title":"J Rheumatol"},{"issue":"12","key":"2211_CR14","first-page":"2330","volume":"24","author":"J Rovensky","year":"1997","unstructured":"Rovensky J, Jurankova E, Rauova L, Blazickova S, Lukac J, Veselkova Z et al (1997) Relationship between endocarine, immune, and clinical variables in patients with systemic lupus erythematosus. J Rheumatol 24(12):2330\u20132334","journal-title":"J Rheumatol"},{"key":"2211_CR15","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"2211_CR16","first-page":"783","volume":"11","author":"MB Urowitz","year":"1984","unstructured":"Urowitz MB, Gladman DD, Tozman EC, Goldsmith CH (1984) The lupus activity criteria count (LACC). J Rheumatol 11:783\u2013787","journal-title":"J Rheumatol"},{"key":"2211_CR17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630\u2013640","journal-title":"Arthritis Rheum"},{"key":"2211_CR18","first-page":"639","volume":"17","author":"N Ben-Jonathan","year":"1996","unstructured":"Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW (1996) Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17:639\u2013669","journal-title":"Endocr Rev"},{"issue":"4","key":"2211_CR19","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"ME Freeman","year":"2000","unstructured":"Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80(4):1523\u20131631","journal-title":"Physiol Rev"},{"key":"2211_CR20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2007-1018876","volume":"10","author":"I Berczi","year":"1992","unstructured":"Berczi I (1992) The immunology of prolactin. Semin Reprod Endocrinol 10:196\u2013219","journal-title":"Semin Reprod Endocrinol"},{"key":"2211_CR21","first-page":"534","volume":"89","author":"E Nagy","year":"1978","unstructured":"Nagy E, Berczi I (1978) Immunodeficiency in hypo-physectomised rats. Acta Endocrinol (Copenh) 89:534\u2013537","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2211_CR22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0162-3109(83)90023-1","volume":"6","author":"E Nagy","year":"1983","unstructured":"Nagy E, Berczi I, Nren GE et al (1983) Immunomodulation by bromocriptine. Immunopharmacology 6:231\u2013243","journal-title":"Immunopharmacology"},{"issue":"1","key":"2211_CR23","first-page":"255","volume":"8","author":"E Chuang","year":"2007","unstructured":"Chuang E, Molitch ME (2007) Prolactin and autoimmune diseases in humans. Acta Biomed 8(1):255\u2013261","journal-title":"Acta Biomed"},{"key":"2211_CR24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1210\/endo-126-1-88","volume":"126","author":"P Mukherjee","year":"1990","unstructured":"Mukherjee P, Mastro AM, Hymer WC (1990) Prolactin induction of IL1 receptors on rat splenic lymphocytes. Endocrinology 126:88\u201394","journal-title":"Endocrinology"},{"key":"2211_CR25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1210\/endo-129-2-983","volume":"129","author":"SM Viselli","year":"1991","unstructured":"Viselli SM, Stanek EM, Murherjee P et al (1991) Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinology 129:983\u2013990","journal-title":"Endocrinology"},{"key":"2211_CR26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0162-3109(87)90004-X","volume":"14","author":"BL Spangelo","year":"1987","unstructured":"Spangelo BL, Hall NRS, Ross PC et al (1987) Stimulation of in vitro antibody production and concanavalin A induced mouse spleen cell mitogenesis by prolactin. Int J Immunopharmacol 14:11\u201320","journal-title":"Int J Immunopharmacol"},{"key":"2211_CR27","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.4049\/jimmunol.134.5.3027","volume":"134","author":"DH Russell","year":"1985","unstructured":"Russell DH, Kibler R, Matrisian L et al (1985) Prolactin receptors on human B and T lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol 134:3027\u20133031","journal-title":"J Immunol"},{"issue":"3","key":"2211_CR28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.60.3.242","volume":"60","author":"AM Jacobi","year":"2001","unstructured":"Jacobi AM, Rohde W, Volk HD, D\u00f6rner T, Burmester GR, Hiepe F (2001) Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls. Ann Rheum Dis 60(3):242\u2013247","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2211_CR29","first-page":"1546","volume":"28","author":"A Lea\u00f1os-Miranda","year":"2001","unstructured":"Lea\u00f1os-Miranda A, Pascoe-Lira D, Ch\u00e1vez-Rueda KA, Blanco-Favela F (2001) Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. J Rheumatol 28(7):1546\u20131553","journal-title":"J Rheumatol"},{"key":"2211_CR30","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1096\/fasebj.3.10.2787766","volume":"3","author":"DP Hartmann","year":"1989","unstructured":"Hartmann DP, Holaday JU, Bernton EW (1989) Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J 3:2194\u20132202","journal-title":"FASEB J"},{"issue":"1","key":"2211_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2007-0017","volume":"29","author":"N Ben-Jonathan","year":"2008","unstructured":"Ben-Jonathan N, LaPensee CR, LaPensee EW (2008) What can we learn from rodents about prolactin in humans? Endocr Rev 29(1):1\u201341","journal-title":"Endocr Rev"},{"key":"2211_CR32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/clin.1994.1095","volume":"71","author":"R McMurray","year":"1994","unstructured":"McMurray R, Keisler D, Kondo K, Walker S (1994) Hyperprolactinemia in male NZB\/NZW (B\/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 71:338\u2013343","journal-title":"Clin Immunol Immunopathol"},{"key":"2211_CR33","first-page":"R30","volume":"33","author":"R McMurray","year":"1990","unstructured":"McMurray R, Keisler D, Walker S (1990) Bromocriptine decreases early mortality in female NZB\/W mice. Arthritis Rheum 33:R30","journal-title":"Arthritis Rheum"},{"key":"2211_CR34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/art.1780310717","volume":"31","author":"A White","year":"1988","unstructured":"White A, Williams O (1988) Bromocriptine treatment suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum 31:927\u2013928","journal-title":"Arthritis Rheum"},{"key":"2211_CR35","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1172\/JCI112921","volume":"79","author":"AG Palestine","year":"1987","unstructured":"Palestine AG, Muellenberg-Coulombre CG, Kim MK et al (1987) Bromocriptine and low dose cyclosporine in the treatment of experimental uveitis in the rat. J Clin Invest 79:1076\u20131081","journal-title":"J Clin Invest"},{"issue":"10","key":"2211_CR36","first-page":"2140","volume":"30","author":"O Vera-Lastra","year":"2003","unstructured":"Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, Espinoza LR (2003) Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment. J Rheumatol 30(10):2140\u20132146","journal-title":"J Rheumatol"},{"issue":"6","key":"2211_CR37","first-page":"807","volume":"20","author":"L Moszkorzov\u00e1","year":"2002","unstructured":"Moszkorzov\u00e1 L, Lacinov\u00e1 Z, Marek J, Musilov\u00e1 L, Dohnalov\u00e1 A, Dost\u00e1l C (2002) Hyperprolactinaemia in patients with systemic lupus erythematosus. Clin Exp Rheumatol 20(6):807\u2013812","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"2211_CR38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1191\/0961203302lu163oa","volume":"11","author":"SG Pasoto","year":"2002","unstructured":"Pasoto SG, Mendon\u00e7a BB, Bonf\u00e1 E (2002) Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus 11(3):175\u2013180","journal-title":"Lupus"},{"key":"2211_CR39","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1191\/096120301717164994","volume":"10","author":"LJ Jara","year":"2001","unstructured":"Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J (2001) Prolactin in human systemic lupus erythematosus. Lupus 10:748\u2013756","journal-title":"Lupus"},{"issue":"10","key":"2211_CR40","first-page":"2216","volume":"28","author":"M Pacilio","year":"2001","unstructured":"Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R (2001) Elevated bioactive prolactin levels in systemic lupus erythematosus\u2013association with disease activity. J Rheumatol 28(10):2216\u20132221","journal-title":"J Rheumatol"},{"issue":"8","key":"2211_CR41","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1191\/096120301701549688","volume":"10","author":"AM Jacobi","year":"2001","unstructured":"Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F (2001) Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 10(8):554\u2013561","journal-title":"Lupus"},{"issue":"3","key":"2211_CR42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000237242","volume":"109","author":"MA Guti\u00e9rrez","year":"1996","unstructured":"Guti\u00e9rrez MA, Molina JF, Jara LJ, Garc\u00eda C, Guti\u00e9rrez-Ure\u00f1a S, Cu\u00e9llar ML et al (1996) Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. Int Arch Allergy Immunol 109(3):229\u2013235","journal-title":"Int Arch Allergy Immunol"},{"key":"2211_CR43","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/ard.2003.018325","volume":"63","author":"MD K\u00f6ller","year":"2004","unstructured":"K\u00f6ller MD, Templ E, Riedl M, Clodi M, Wagner O, Smolen JS et al (2004) Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus. Ann Rheum Dis 63:1677\u20131680","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2211_CR44","first-page":"843","volume":"21","author":"RW McMurray","year":"1994","unstructured":"McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE (1994) Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol 21(5):843\u2013850","journal-title":"J Rheumatol"},{"issue":"5","key":"2211_CR45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00002281-199509000-00006","volume":"7","author":"M Petri","year":"1995","unstructured":"Petri M (1995) Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol 7(5):395\u2013401","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"2211_CR46","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1568-9972(02)00081-2","volume":"1","author":"O Vera-Lastra","year":"2002","unstructured":"Vera-Lastra O, Jara LJ, Espinoza LR (2002) Prolactin and autoimmunity. Autoimmun Rev 1(6):360\u2013364","journal-title":"Autoimmun Rev"},{"key":"2211_CR47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1398.044","volume":"1109","author":"H Orbach","year":"2007","unstructured":"Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G et al (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci 1109:385\u2013400","journal-title":"Ann NY Acad Sci"},{"key":"2211_CR48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11102-005-5082-5","volume":"8","author":"A Bellis De","year":"2005","unstructured":"De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A (2005) Prolactin and autoimmunity. Pituitary 8:25\u201330","journal-title":"Pituitary"},{"key":"2211_CR49","first-page":"2084","volume":"2","author":"RW McMurray","year":"1995","unstructured":"McMurray RW, Weidensaul D, Allen SH, Walker SE (1995) Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 2:2084\u20132091","journal-title":"J Rheumatol"},{"key":"2211_CR50","first-page":"2064","volume":"11","author":"R Pauzner","year":"1994","unstructured":"Pauzner R, Urowitz MR, Gladman DD, Gough JM (1994) Prolactin in systemic lupus erythematosus. J Rheumatol 11:2064\u20132067","journal-title":"J Rheumatol"},{"key":"2211_CR51","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1530\/eje.0.1300434","volume":"130","author":"N Hattori","year":"1994","unstructured":"Hattori N, Ikekwbo K, Ishihara T et al (1994) Effect of anti-prolactin autoantibodies on serum prolactin measurements. Eur J Endocrinol 130:434\u2013437","journal-title":"Eur J Endocrinol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2211-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2211-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2211-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T23:47:22Z","timestamp":1686440842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2211-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,8]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["2211"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2211-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,8]]}}}